Log in to save to my catalogue

Nanotechnology-empowered combination therapy for rheumatoid arthritis: principles, strategies, and c...

Nanotechnology-empowered combination therapy for rheumatoid arthritis: principles, strategies, and c...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_7a0667dd861d44759c7fd04690e91229

Nanotechnology-empowered combination therapy for rheumatoid arthritis: principles, strategies, and challenges

About this item

Full title

Nanotechnology-empowered combination therapy for rheumatoid arthritis: principles, strategies, and challenges

Publisher

England: BioMed Central Ltd

Journal title

Journal of nanobiotechnology, 2024-07, Vol.22 (1), p.431-33, Article 431

Language

English

Formats

Publication information

Publisher

England: BioMed Central Ltd

More information

Scope and Contents

Contents

Rheumatoid arthritis (RA) is an autoimmune disease with multifactorial etiology and intricate pathogenesis. In RA, repeated monotherapy is frequently associated with inadequate efficacy, drug resistance, and severe side effects. Therefore, a shift has occurred in clinical practice toward combination therapy. However, conventional combination therap...

Alternative Titles

Full title

Nanotechnology-empowered combination therapy for rheumatoid arthritis: principles, strategies, and challenges

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_7a0667dd861d44759c7fd04690e91229

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_7a0667dd861d44759c7fd04690e91229

Other Identifiers

ISSN

1477-3155

E-ISSN

1477-3155

DOI

10.1186/s12951-024-02670-7

How to access this item